There was evidence suggesting that AMP-activated serine/threonine protein kinase (AMPK) negatively regulates the mammalian target of rapamycin (mTOR) to promote autophagy, which is crucial in preventing T1DM (31, 32). Here, MTOR is linked to type 1 diabetes mellitus.